At a glance
- Originator Nisshin Pharma
- Class Antidementias; Neuroprotectants
- Mechanism of Action Nitric oxide stimulants; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 11 Sep 2000 Discontinued-Preclinical for Neurological disorders (Prevention) in Japan (Unknown route)
- 20 Nov 1996 Preclinical development for Neurological disorders (Prevention) in Japan (Unknown route)